Buy or sell Intuitive Surgical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Intuitive Surgical Stock

The da Vinci Surgical System is changing the experience of surgery for patients around the world.

About Intuitive Surgical Stock

Intuitive Surgical is a developer of robotic-assisted minimally invasive surgery (MIS) techniques and tools. The Company's da VinciÂ® Surgical System offers surgeons superior visualization, enhanced dexterity, greater precision and ergonomic comfort for the optimal performance of MIS. The da Vinci System enables surgeons to perform even complex procedures such as open-heart surgery through 1-2 cm incisions.

Management

Vice President, da Vinci Professional Education & Program Services - Worldwide

Gillian Duncan

Sr. VP Quality & Regulatory Quality

Mark Johnson

Senior Vice President of Global Sales Operations and Strategy

Glenn Vavoso

VP Digital & Data Development

Liron Leist

VP, Global Public Affairs

Paige Bischoff

Clinical Territory Associate

Joseph Benevento

Marketing Director

Doug Hutchison

SVP , US Sales

Henry Charlton

SVP & CMO

Myriam Curet

Senior Test Engineer

Robert Last

Press

Why Did R&D Jump 2x In 4 Years For Intuitive Surgical?

Forbes - Dec, 3 2019

Intuitive Surgical’s Revenue Growth Could Slow?

Forbes - Oct, 28 2019

What Led To 60% Growth In Intuitive Surgical’s Stock Over The Last Two Years?

Forbes - Oct, 2 2019

This Is How 5G May Save Your Life

Forbes - Aug, 29 2019

Look Under The Hood: The Invesco QQQ ETF Has 10% Upside

Forbes - Aug, 1 2019

After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt

TechCrunch - Jul, 9 2019

What's Driving Our $567 Price Estimate For Intuitive Surgical?

Forbes - May, 16 2019

Other Companies

Learn More

ClassPass

Alternative gym membership

Cresilon is a medical device company that produces and markets solutions for trauma care.

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

Synthetic Genomics develops genomic-driven solutions to address global energy and environmental challenges.

15Age (years)

$40.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Intuitive Surgical or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.